Objectives In type 2 diabetes (T2DM), low dose Aspirin has been established for secondary cardiovascular prevention, but as yet there is no definitive data showing primary cardiovascular prevention.We hypothesized that a double dose of ASA would further reduce platelet reactivity and, given the increased platelet turnover, may be most effective when given in divided doses twice-daily.